| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.009 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |